244 related articles for article (PubMed ID: 29458956)
1. Incidence and Economic Impact of Incidental Findings on
Adams SJ; Rakheja R; Bryce R; Babyn PS
Can Assoc Radiol J; 2018 Feb; 69(1):63-70. PubMed ID: 29458956
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of non
Sheldon JA; Yap KK; Taubman KL; Schlicht SM
J Med Imaging Radiat Oncol; 2018 Apr; 62(2):194-202. PubMed ID: 29230956
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
Shmidt E; Nehra V; Lowe V; Oxentenko AS
BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
[TBL] [Abstract][Full Text] [Related]
4. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
5. Does FDG-PET/CT for incidentally found pulmonary lesions lead to a cascade of more incidental findings?
Sluijter TE; Yakar D; Roest C; Tsoumpas C; Kwee TC
Clin Imaging; 2024 Apr; 108():110116. PubMed ID: 38460254
[TBL] [Abstract][Full Text] [Related]
6. Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer.
Casselden E; Sheerin F; Winter SC
Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):243-247. PubMed ID: 30535976
[TBL] [Abstract][Full Text] [Related]
7. Incidental Findings on FDG PET/CT in Head and Neck Cancer.
Britt CJ; Maas AM; Kennedy TA; Hartig GK
Otolaryngol Head Neck Surg; 2018 Mar; 158(3):484-488. PubMed ID: 29160180
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials.
Wan MT; Torigian DA; Alavi A; Alvarez J; Chiesa Fuxench ZC; Noe MH; Papadopoulos M; Shin DB; Takeshita J; Werner TJ; Mehta NN; Gelfand JM
J Am Acad Dermatol; 2019 Jun; 80(6):1630-1639. PubMed ID: 30654078
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation.
Guo HH; Moradi F; Iagaru A
Nucl Med Commun; 2016 Sep; 37(9):975-82. PubMed ID: 27111100
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Brain Metastases on Follow-up
Nia ES; Garland LL; Eshghi N; Nia BB; Avery RJ; Kuo PH
J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of conventional whole-body ¹⁸F-FDG PET/CT in the incidental findings of parotid masses.
Wang HC; Zuo CT; Hua FC; Huang ZM; Tan HB; Zhao J; Guan YH
Ann Nucl Med; 2010 Oct; 24(8):571-7. PubMed ID: 20640540
[TBL] [Abstract][Full Text] [Related]
13. Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
Reesink DJ; Fransen van de Putte EE; Vegt E; De Jong J; van Werkhoven E; Mertens LS; Bex A; van der Poel HG; van Rhijn BW; Horenblas S; Meijer RP
J Urol; 2016 Apr; 195(4 Pt 1):907-12. PubMed ID: 26598424
[TBL] [Abstract][Full Text] [Related]
14. Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer.
Tae CH; Lee JH; Choi JY; Min BH; Rhee PL; Kim JJ
Asia Pac J Clin Oncol; 2015 Mar; 11(1):34-40. PubMed ID: 25560093
[TBL] [Abstract][Full Text] [Related]
15. An Australian local diagnostic reference level for paediatric whole-body
Alkhybari EM; McEntee MF; Willowson KP; Brennan PC; Kitsos T; Kench PL
Br J Radiol; 2019 Apr; 92(1096):20180879. PubMed ID: 30653334
[TBL] [Abstract][Full Text] [Related]
16. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
[TBL] [Abstract][Full Text] [Related]
17. Role of
Albano D; Bosio G; Giubbini R; Bertagna F
Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
[TBL] [Abstract][Full Text] [Related]
18. Detection of incidental colorectal pathology on positron emission tomography/computed tomography.
Mui M; Akhurst T; Warrier SK; Lynch AC; Heriot AG
ANZ J Surg; 2018 Mar; 88(3):E122-E126. PubMed ID: 27580915
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of
Hung WT; Liu CJ; Liu YL; Ko KY; Chou SW; Chang HH; Yang YL; Lu MY; Hsu WM
Pediatr Blood Cancer; 2024 Jul; 71(7):e30983. PubMed ID: 38605509
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological analysis and risk factors of advanced colorectal neoplasms incidentally detected by 18F-FDG PET-CT.
Chung SM; Kim KO; Cho IH; Kim TN
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):407-413. PubMed ID: 27926665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
